ANSWERS | GRADED A+
1. Women aged 65 and older AND younger women with fracture risk of 9.3%
or higher: screen for osteoporosis with DEXA
2. Ibuprofen / naproxen for primary dysmenorrhea, if side effect or not con-
trolled,: OCP
3. Reduce risk of pressure ulcers in at risk-patients: use advanced static mat-
tresses of overlays
4. life expectancy of at least --- years is expected to benefit from screening
mammography: 10 years
5. Frequent episodes of binge eating >1/week followed by innapropriate com-
pensatory behaviors (vomiting, laxatives,enema etc) due to fear of gaining
weight: Bulimia nervosa
6. anorexia BMI: generally underweight, or less than 18.5
7. otitis media with effusion management: observe, usually resolves in 12 weeks
8. otitis externa treatment: combined antibiotic and glucocorticoid ototopical med-
ication, ee.g neomycin +polymyxin b +hydrocortisone
9. topical lidocaine is effective in treatment of herpetic neuralgia: topical lido-
caine
10. describe uveitis: unilateral eye pain, photophobia, ciliary flush (Circumferential
redness along the border of the sclera and cornea), there may be miosis
,11. Indications for bariatric surgery: BMI 40 or higher without comorbidities, BMI
35 with comorbities
12. Orlistat: Weight loss medication, loose stool common side effect. Lose about
3.5kg over 1 year
13. Lorcaserin: Weight loss medication, avoid in pts taking SSRIs sue to elevation
in serotonin
14. Phentermine-topiramate: Weight loss medication, avoid in glaucoma
15. acromioclavicular join degeneration presentation: pain on superior aspect
of shoulder, tenderness on palpation of A-C joint, pain with shoulder adduction and
abduction >120 degrees
16. Supraspinatus tear test: Positive drop arm test
17. supraspinatus tendinitis: pain on shoulder abduction or painful arc
18. Lung cancer screening: ANNUAL LOW-DOSE CT for age 55-80 years with
30-pack year smoking history, including those who quit within 15 years
19. AAA Screening: One time abdominal US for men 65-75 who have smoked at
least 100 cigarrettes
20. standard outcome measure for cohort study: relative risk
21. Treatment options for bipolar depression: Seroquel monotherapy, combina-
tion olanzapine-fluoxetine
2 M/ M29
, 22. hormonal estrogen is contraindicated in women with migraines+aura M M M M M M M
due to risk of: stroke
M M M M M
23. PAP smear screening: women 21-65 , every 3 years. In women 30 - 65,
M M M M M M M M M M M M M
every 5 years if combined with HPV testing
M M M M M M M M
24. Indications for high intensity statin: Age 40 - 75 with diabetes and an LDLM M M M M M M M M M M M M
of 70 - 189,and 10 years >7.5% ASCVD risk
M M M M M M M M M
25. men with low or low-normal testosterone level should have a repeat
M M M M M M M M M M
con- firmatory morning testosterone prior to begining testosterone
M M M M M M M M
treatment:
M
26. severe vasomotor symptoms in postmenopausal women are best
M M M M M M M
treated with: systemic hormonal therapy;- oral estradiol-progrestin combo
M M M M M M M M
27. test to be performed in all patients with syncope: EKG
M M M M M M M M M
28. Panic disorder treatment: SSRI (sertraline), SNRI, TCAs, MAOi
M M M M M M M
29. Trichomoniasis treatment: single dose of metronidazole 2g, and treat partner M M M M M M M M M
30. Treatment of vasomotor symptoms in postmenopausal women without M M M M M M M
a uterus: Transdermal or oral Estradiol only (no need for progestin as they
M M M M M M M M M M M M M
have no uterus)
M M M
31. Statins, ACE-i/ARB are teratogenic: discontinue in pregnant women
M M M M M M M
32. Indications for pharmacologic weight loss treatment: BMI greater than M M M M M M M M
30, or BMI greater than 27 with obesity associated complications
M M M M M M M M M M
33. Indications for BRCA gene testin: 1. Bilateral breast cancer 2. presence M M M M M M M M M M
of both breast and ovarian cancer 3. breast cancer before the age of 50 4.
M M M M M M M M M M M M M M M
Ashkenazi Jews 5. multiple family members with breast cancer 6. 1 or more
M M M M M M M M M M M M M
family males with breast cancer
M M M M M
If high risk found, FIRST offer genetic counselling BEFORE testing for BRCA
M M M M M M M M M M M
3 M/ M29